Last reviewed · How we verify
NCT06758323
Acute Effects of Beetroot Juice and Caffeine Co-ingestion on Lower-limb Strength and Muscular Endurance in Females
NA trial testing Beetroot juice combined with caffeine (COM) in Beetroot Juice in 15 participants. Completed in 26 December 2024.
26 December 2024
Quick facts
| Lead sponsor | Jose Manuel Jurado Castro |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 1 August 2024 |
| Primary completion | 26 December 2024 |
| Estimated completion | 26 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Beetroot juice combined with caffeine (COM)
- Beetroot juice placebo with caffeine (CAF)
- Beetroot juice with caffeine placebo (BRJ)
- Beetroot placebo with caffeine placebo (PLA)
Conditions studied
- Beetroot Juice — all drugs for Beetroot Juice →
- Caffeine — all drugs for Caffeine →
- Placebo — all drugs for Placebo →
- Beetroot Juice with Caffeine Co-ingestion — all drugs for Beetroot Juice with Caffeine Co-ingestion →
Sponsor
Jose Manuel Jurado Castro
Who can join
Adults 18 to 35, female only, with Beetroot Juice or Caffeine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the acute effects of beetroot juice and caffeine, consumed individually or in combination, on lower-limb strength and muscular endurance in physically active women. The main questions it aims to answer are: * Does the co-ingestion of beetroot juice and caffeine enhance lower-limb strength and muscular endurance more than either substance alone or a placebo? * How do the acute effects of beetroot juice interact with caffeine on physical performance? The study was conducted using a randomized, crossover design to evaluate the following four conditions: Beetroot juice with placebo Caffeine with placebo Beetroot juice with caffeine Placebo only Each participant completed all conditions, with a sufficient washout period between sessions to eliminate potential carryover effects. This design allowed for a direct comparison of the acute effects of each supplementation strategy on lower-limb strength and muscular endurance. Participant Protocol Participants consumed their assigned supplement on a single testing day for each condition. After supplementation, they performed standardized tests to measure lower-limb strength and muscular endurance. Progress was monitored, and data from all conditions were collected to assess the acute effects of each intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06758323
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06758323 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jose Manuel Jurado Castro
- Last refreshed: 6 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06758323.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing